Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques
about
Stabilizing role of platelet P2Y(12) receptors in shear-dependent thrombus formation on ruptured plaquesRac1-mediated signaling plays a central role in secretion-dependent platelet aggregation in human blood stimulated by atherosclerotic plaque.Lysophosphatidic acid in atherosclerotic diseasesEchicetin coated polystyrene beads: a novel tool to investigate GPIb-specific platelet activation and aggregationEffects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrelCurrent concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.Platelets and von Willebrand factor in atherogenesis.Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
P2860
Q28752603-61F77928-CA4A-450F-B60E-54818CCE721EQ30497856-0AA15DF2-00C8-4784-A826-B3823024F426Q34273486-4CD375B8-82D5-4EA9-BF83-B82438754DEEQ35140258-04B8F988-381C-4367-A10D-B5E13AB05DCDQ36153265-59CAA9F4-C411-443F-A854-525F3DA2745BQ37827566-A121B57D-88BE-498B-B151-97AFE81B1656Q39125083-E3E4929C-BBE8-473E-8233-662D18ED7D6BQ41578105-97CEB434-F282-4ACB-B793-58306A762C86Q41628315-3AC9B4B6-1873-4F74-AEBC-3DD55EBDD9F9
P2860
Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Glycoprotein Ibalpha inhibitio ...... sed to atherosclerotic plaques
@ast
Glycoprotein Ibalpha inhibitio ...... sed to atherosclerotic plaques
@en
Glycoprotein Ibalpha inhibitio ...... sed to atherosclerotic plaques
@nl
type
label
Glycoprotein Ibalpha inhibitio ...... sed to atherosclerotic plaques
@ast
Glycoprotein Ibalpha inhibitio ...... sed to atherosclerotic plaques
@en
Glycoprotein Ibalpha inhibitio ...... sed to atherosclerotic plaques
@nl
prefLabel
Glycoprotein Ibalpha inhibitio ...... sed to atherosclerotic plaques
@ast
Glycoprotein Ibalpha inhibitio ...... sed to atherosclerotic plaques
@en
Glycoprotein Ibalpha inhibitio ...... sed to atherosclerotic plaques
@nl
P2093
P356
P1476
Glycoprotein Ibalpha inhibitio ...... sed to atherosclerotic plaques
@en
P2093
Armin J Reininger
Orsolya Toth
Richard Brandl
Sandra M Penz
Wolfgang Siess
P304
P356
10.1160/TH06-07-0415
P407
P50
P577
2007-03-01T00:00:00Z